ALKS Shane Cooke sells $2.1M worth of shares
Feb 03, 2026, 5:33 AM
0.00%
What does ALKS do
Alkermes Plc is a biopharmaceutical company based in Dublin, focused on developing treatments for alcohol and opioid dependence, schizophrenia, and bipolar I disorder, employing 2,100 people. Its key products include LYBALVI, ARISTADA, and VIVITROL, with ongoing development for neurological disorders and cancer.
Shane Cooke sold 61,200 shares of ALKS on 2 February at $34.78 per share, worth a total of $2.1M. They now own 135,857 ALKS shares, or a 37% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.